Stocks
GlaxoSmithKline (GSK) EV US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV, £ | ? | 154 583 640 000 | 165 189 660 000 | 91 446 892 800 | 82 214 070 000 | 63 954 101 000 | 120 238 573 000 | ||
| Changes by years, y/y, % | +84% | +7% | -45% | -10% | -22% | -7.4% | |||
GlaxoSmithKline. EV, £
GlaxoSmithKline. EV, changes, %
GlaxoSmithKline (GSK) EV US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV, £ | ? | 97 186 650 250 | 96 831 357 250 | 106 498 955 000 | 63 561 781 000 | 131 603 548 000 | 120 238 573 000 | |
| Changes by years, y/y, % | -4% | -43% | +11% | -23% | +35% | |||
| Changes by quarters, q/q, % | +18% | 0% | +10% | -40% | +107% | |||
